Geron Q4 RYTELO revenue $48M, FY2025 $184M; guides FY2026 revenue $220-240M

GERON CORP

2025-FY EPS reported -$0.13

Q4 2025 RYTELO net product revenue $48.0M; full year $183.6M. Net loss $31.1M in Q4, $85.8M for 2025.
FY2025 ended with $401.1M cash; FY2026 guidance: RYTELO revenue $220-240M, total opex $230-240M.
Q4 RYTELO demand grew 9% sequentially; ordering accounts increased by 150 to ~1,300.
Recorded $17.0M restructuring charge in Q4 from workforce reduction of ~1/3.
Announced three new publications and initial data expected H2 2026 from investigator-sponsored trials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.